Page 2 - Les meilleurs doctors traitant la maladie suivante : Gliome - TOP -67 des médecins

La Dre Viola Fox dirige la clinique d'hématologie, d'oncologie et de soins palliatifs du BKZ de Solingen, forte de plus de 15 ans d'expérience spécialisée dans le traitement des gliomes et d'autres tumeurs.

• Se spécialiser en chimiothérapie, immunothérapie et thérapies ciblées
• Se qualifier en génétique pour améliorer les approches de traitement personnalisé
• S’impliquer dans la recherche en biologie moléculaire pour des thérapies innovantes contre le cancer
• Être membre de sociétés d'oncologie allemandes et américaines

Le professeur Keil est spécialisé dans les techniques d'imagerie avancées pour le gliome, avec une expertise en radiologie diagnostique et interventionnelle à l'Hôpital Académique de Solingen.

• Diplômé avec mention de l'Université Julius-Maximilian de Wurtzbourg
• Plus de 16 ans d'expérience en radiologie, y compris dans le diagnostic par IRM et scanner
• Ancien médecin chef à la Clinique Universitaire d'Aix-la-Chapelle
• Spécialisé dans l'imagerie transversale pour les interventions médicales complexes

Le professeur Elke Jaeger a réalisé plus de 1 100 traitements de gliomes et figure parmi les meilleurs oncologues d'Allemagne depuis plus de 20 ans.

• 38 ans de spécialisation en oncologie et hématologie
• Chef du service d'oncologie à la clinique Nordwest
• Reconnue comme spécialiste de premier plan des sarcomes
• Classée parmi les meilleurs oncologues par le magazine Focus

Le professeur Shlomi Constantini est spécialisé dans la chirurgie des gliomes et est un membre primé de l’American Association of Neurological Surgeons.

• Réaliser des interventions microchirurgicales et neuro-endoscopiques avancées
• Se former en Europe à la chirurgie des tumeurs supratentorielles et infratentorielles
• Détenir des prix de recherche pour des études sur la pression intracrânienne et la recherche clinique
• Être membre de la Société Européenne de Neurochirurgie Pédiatrique et de la Fédération Internationale de Neuroendoscopie
• Traiter les tumeurs cérébrales chez les adultes et les enfants au centre médical Sourasky

Neurochirurgien de renommée mondiale, le Pr Zvi Ram dirige l'Association Européenne des Sociétés de Neurochirurgie et propose des soins innovants contre les gliomes au centre médical Sourasky.

• Expert en chirurgie complexe des tumeurs cérébrales avec cartographie cérébrale et stimulation cérébrale profonde
• Hautement qualifié en techniques microsurgicales et guidées par l'image pour les tumeurs cérébrales
• Mène des recherches de pointe sur les thérapies géniques du cancer du cerveau
• Lauréat du prix de la Fondation Goldhirsh pour ses traitements neurologiques innovants

Le Dr Yildiz possède plus d'une décennie d'expérience spécialisée en oncologie, se concentrant sur les cas de cancer avancés à l'hôpital universitaire Medipol Mega.

• Plus de 15 ans d'expérience en oncologie médicale
• Titulaire d'un poste de professeur en oncologie – un expert qui forme d'autres médecins
• Auteur de nombreuses publications dans des revues médicales internationales sur divers types de cancer
• Membre de la Société européenne d'oncologie médicale (ESMO)
• Intérêt particulier pour les tumeurs neuroendocrines et la gestion des cas complexes

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Spécialiste en virothérapie – l'un des domaines les plus récents de l'immunologie – avec plus de 30 ans d'expérience à la Clinique Pallas.

• Chef du centre d'immunologie clinique de l'hôpital universitaire clinique Pauls Stradins
• Diplômé de l'Institut de médecine de Riga
• Internat en médecine interne

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Le Prof. Assoc. Nail Paksoy est un oncologue médical spécialisé dans le traitement des gliomes à l'hôpital Medipol Bahçelievler, titulaire de la certification de l'ESMO et doté d'une vaste expérience en recherche.

• Formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul
• Participation à 8 essais cliniques internationaux pour les traitements contre le cancer
• Publication de plusieurs études sur les tumeurs cérébrales et la neuro-oncologie
• Certifié par l'ESMO en oncologie médicale

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Le Dr Alemdar est spécialisé en oncologie médicale, ayant suivi une formation approfondie à l'Université d'Akdeniz, un établissement de référence pour les soins oncologiques.

• Certifié en oncologie médicale depuis 2018
• Plus de 15 ans d'expérience en oncologie
• Exerce au complexe hospitalier Medical Park Antalya

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Pionnier dans la définition de critères stricts pour les syndromes neurologiques paranéoplasiques – le Dr Graus est une figure de proue de la neuro-oncologie à l'Hospital Quiron Barcelona.

• Ancien chef du service de neurologie à l'Hospital Clinic de Barcelone
• Fondateur et ancien président de l'Association européenne de neuro-oncologie
• Formé en neuro-oncologie au Memorial Sloan-Kettering Cancer Center
• Distingué par le titre de Doctor Honoris Causa de l'Université de Lyon